Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in medicinal chemistry due to its ability to form stable heterocyclic structures that enhance binding affinity to biological targets. Commonly employed in the preparation of antiviral and anticancer agents, especially in structure-activity relationship (SAR) studies where the piperazine-pyrimidine scaffold improves pharmacokinetic properties. Also utilized in the creation of receptor agonists and antagonists targeting neurological and inflammatory disorders. Its dihydrochloride form enhances solubility and stability, making it suitable for formulation in early drug discovery and high-throughput screening.